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Abstract 
This study investigated how sample size affects the reproducibility of findings 
from univariate voxel-based lesion-deficit analyses (e.g., voxel-based lesion-
symptom mapping and voxel-based morphometry). Our effect of interest was the 
strength of the mapping between brain damage and speech articulation difficulties, 
as measured in terms of the proportion of variance explained. First, we identified a 
region of interest by searching on a voxel-by-voxel basis for brain areas where 
greater lesion load was associated with poorer speech articulation using a large 
sample of 360 right-handed English-speaking stroke survivors. We then randomly 
drew thousands of bootstrap samples from this data set that included either 30, 60, 
90, 120, 180, or 360 patients. For each resample, we recorded effect size estimates 
and p values after conducting exactly the same lesion-deficit analysis within the 
previously identified region of interest and holding all procedures constant. The 
results show (1) how often small effect sizes in a heterogeneous population fail to be 
detected; (2) how effect size and its statistical significance varies with sample size; 
(3) how low-powered studies (due to small sample sizes) can greatly over-estimate 
as well as under-estimate effect sizes; and (4) how large sample sizes (N ≥ 90) can 
yield highly significant p values even when effect sizes are so small that they 
become trivial in practical terms. The implications of these findings for interpreting 
the results from univariate voxel-based lesion-deficit analyses are discussed. 
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voxel-based; lesion-symptom; lesion; deficit; reproducibility; stroke; speech 
production 
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1. Introduction 1 
There is a great deal of evidence showing how both false positive and false 2 
negative results increase as sample size decreases (Bakker et al., 2012; Button et 3 
al., 2013a; Chen et al., 2018; Cremers et al., 2017; Ingre, 2013; Ioannidis, 2008) and 4 
how inadequate statistical power can lead to replication failures (Anderson et al., 5 
2017; Bakker et al., 2012; Perugini et al., 2014; Simonsohn et al., 2014a; Szucs and 6 
Ioannidis, 2017). However, the impact of sample size on false negative and false 7 
positive rates has never been quantified in mass-univariate voxel-based lesion-deficit 8 
mapping (e.g., voxel-based lesion-symptom mapping and voxel-based 9 
morphometry). Using data from a large sample of stroke patients, we firstly 10 
estimated the magnitude of a lesion-deficit mapping of interest and then formally 11 
investigated how effect size and its statistical significance varies with sample size. In 12 
addition to demonstrating how small samples can result in over- and under-13 
estimations of effect size, we also highlight an issue with large sample sizes whereby 14 
high statistical power dramatically increases the likelihood of detecting effects that 15 
are so small that they become uninteresting from a scientific viewpoint (i.e. the 16 
fallacy of classical inference; Friston et al., 2012). In other words, statistically 17 
significant findings when sample sizes are large can hide the fact that the effect 18 
under investigation might be of little importance in practical terms, or, even worse, 19 
the result of random chance alone and thereby a false positive (Smith and Nichols, 20 
2018).  21 
To investigate the effect of sample size on the results of univariate voxel-22 
based lesion-deficit mapping, we randomly drew thousands of resamples (with a 23 
range of sample sizes) from a set of data from 360 stroke survivors who had 24 
collectively acquired a wide range of left hemisphere lesions and cognitive 25 
impairments. By using a single patient population and holding all procedures and 26 
analyses constant, we ensured that variability in the results across thousands of 27 
random resamples cannot be explained by methodological confounds - such as the 28 
use of dissimilar recruitment strategies and/or behavioural assessments - that are 29 
likely to influence the findings of studies that aggregate data from multiple 30 
independent sources (e.g., meta-analyses; Müller et al., 2018). Furthermore, by 31 
performing our statistical analyses on actual data, rather than running simulations on 32 
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synthetically-generated data, we attempt to recreate real-world scenarios that could 33 
be encountered by researchers conducting lesion-deficit mapping studies. 34 
The goal of our resampling procedure was to estimate the degree to which the 35 
magnitude and statistical significance of the exact same lesion-deficit mapping (i.e. 36 
brain areas where damage is associated with difficulties articulating speech) 37 
changed with sample size. We report the frequency of significant and non-significant 38 
effects (using standard significance thresholds) for 6 different sample sizes: N = 30, 39 
60, 90, 120, 180 and 360. In a real world situation where only one sample is typically 40 
analysed, results are far more likely to be published when they reach statistical 41 
significance (i.e. the associated p values are below a certain alpha threshold) than 42 
when they fail to produce any evidence in favour of the tested hypothesis. This is 43 
known as “publication bias” (e.g., Fusar-Poli et al., 2014; Ioannidis et al., 2014; 44 
Johnson et al., 2017; Simonsohn et al., 2014a). For example, the prevalence of 45 
“positive” (i.e. statistically significant) findings across a wide range of publication 46 
outlets, including neuroscience and psychology, has been shown to be well over 47 
80% (Fanelli, 2010, 2012), which suggests that the vast majority of studies that yield 48 
“negative” findings are left unpublished. This is known as “the file drawer problem” 49 
(Franco et al., 2014; Simonsohn et al., 2014b). Moreover, the number of “positive” 50 
results in the fMRI (David et al., 2013) and brain volume abnormalities (Ioannidis, 51 
2011) literature has been demonstrated to be significantly greater than the number 52 
expected on the basis of statistical power considerations.   53 
By leaving non-significant results in the file drawer, it becomes increasingly 54 
difficult to ascertain which effects are true (and would replicate in subsequent 55 
studies) and which are false (and would not replicate in subsequent studies). A 56 
highly significant result from a heterogeneous population could, for example, be 57 
driven by random noise when a study selects, by chance, a sample that renders an 58 
inflated (unstandardized) effect size and under-estimated variance. In line with this 59 
rationale, it has been claimed that more than 50% of all significant effects reported in 60 
cognitive neuroscience and psychology journals are likely to correspond to false 61 
positives (Szucs and Ioannidis, 2017).  62 
Our study therefore speaks directly to the “replication crisis” that is currently 63 
being highlighted in psychology and neuroscience (Forstmeier et al., 2017; Gelman 64 
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and Geurts, 2017; Ioannidis, 2005; Loken and Gelman, 2017; Munafò et al., 2017; 65 
Pashler and Wagenmakers, 2012). In the field of psychology, for example, a large-66 
scale collaborative initiative reported that it could only successfully replicate less 67 
than 40% of original effects from a representative set of one hundred randomly 68 
selected studies (Open Science Collaboration, 2015). Similar failed replication 69 
attempts have also been recorded in other research areas including those 70 
investigating structural brain-behaviour correlations (Boekel et al., 2015) and the 71 
blood-oxygen-level-dependent response (Chen et al., 2018; Wende et al., 2017). 72 
2. Materials and Methods 73 
2.1. Participants 74 
Data from all participants were retrieved from the Predicting Language 75 
Outcome and Recovery After Stroke (PLORAS) database (Price et al., 2010; Seghier 76 
et al., 2016). At a minimum, the data available for each patient included: a full 77 
assessment of speech and language abilities and a 3D lesion image, in standard 78 
space, created from a T1-weighted high resolution (1 mm isotropic voxels) 79 
anatomical whole-brain volume, using our automated lesion identification software 80 
(Seghier et al., 2008). The study was approved by the Joint Research Ethics 81 
Committee of the National Hospital for Neurology and Neurosurgery and the Institute 82 
of Neurology. All patients gave written informed consent prior to participation and 83 
were compensated for their time. 84 
Our patient selection criteria included all adult stroke survivors who: (i) had a 85 
left-hemisphere lesion (as attested by a clinical neurologist: co-author A.P.L.) that 86 
was greater than 1 cm3 (as measured by our automated lesion identification tool; 87 
Seghier et al., 2008); (ii) had no history of neurological or psychiatric illness that was 88 
not related to their stroke; (iii) were right-handed (pre-morbidly); and, (iv) were native 89 
speakers of English. Additionally, individuals who had missing scores on the tasks of 90 
interest (see below for details) were excluded from the study. These criteria were 91 
met by a total of 363 stroke patients whose data were collected between April 2003 92 
and December 2016. To ensure that our full sample could be divided evenly into 93 
smaller resampled data sets (see below for details), we additionally excluded from 94 
any further analyses the 3 patients with the smallest lesions (i.e. 1.2, 1.3 and 1.4 cm3 95 
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in size). See Table 1 for demographic and clinical details of the full sample of 360 96 
stroke patients. 97 
2.2. Behavioural assessment 98 
All patients recruited to the PLORAS database are assessed on the 99 
Comprehensive Aphasia Test (CAT) (Swinburn et al., 2004). The CAT is a fully 100 
standardised test battery, which consists of a total of 27 different tasks. For ease of 101 
comparison across tasks, the authors of the CAT encourage the conversion (through 102 
a non-linear transformation) of raw scores into T-scores, which represent how well 103 
the patient performed relative to a reference population of 113 patients with aphasia, 104 
56 of whom were tested more than once. For example, a T-score of 50 indicates the 105 
mean of the patient sample used to standardise the CAT, whereas a T-score of 60 106 
represents one standard deviation above the mean. Most people without post-stroke 107 
aphasia would therefore be expected to score above the average of the patient 108 
standardisation sample on any given task from the CAT. The threshold for 109 
impairment is deﬁned relative to a second reference population of 27 neurologically-110 
normal controls. Specifically, it is the point below which the score would place the 111 
patient in the bottom 5% of the control population (Swinburn et al., 2004). Lower 112 
scores indicate poorer performance. Importantly, the two standardisation samples 113 
referred to before (i.e. 113 patients with aphasia and 27 neurologically-normal 114 
controls) are completely independent of the data we report in the current paper (for 115 
more details on the standardisation samples, see Swinburn et al., 2004). 116 
As stated in the CAT manual (p. 71), the main advantages of converting raw 117 
scores into T-scores is that this allows: (i) scores from different tasks to be compared 118 
because they have been put on a common scale; and (ii) the use of parametric 119 
statistics given that T-scores are normally distributed scores with a mean of 50 and a 120 
standard deviation of 10. 121 
The current study focused exclusively on a total of 5 tasks from the CAT. Task 122 
1 used nonword repetition to assess the patient’s ability to articulate speech. Task 2 123 
used written picture naming to test the patient’s ability to find the names of objects 124 
(lexical/phonological retrieval). Tasks 3-5 tested the patient’s ability to recognise, 125 
process and remember the semantic content of pictures and auditory words. Task 126 
details were as follows: 127 
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Task 1: The CAT nonword repetition (Rep-N) task aurally presents five nonsense 128 
words (e.g., gart), one at a time, with instructions to repeat them aloud. Immediate 129 
correct responses were given a score of 2; incorrect responses were given a score 130 
of 0; correct responses after a self-correction or a delay (> 5 seconds) were given a 131 
score of 1. Articulatory errors (e.g., dysarthric distortions) not affecting the perceptual 132 
identity of the target were scored as correct. Verbal, phonemic, neologistic and 133 
apraxic errors were scored as incorrect. T-scores equal to or below 51 constitute the 134 
impaired range. 135 
Task 2: The CAT written picture naming (Writt-PN) task visually presents five 136 
pictures of objects (e.g., tank), one at a time, with instructions to write their names 137 
down. Letters in the correct position were given a score of 1 each. Substitutions, 138 
omissions and transpositions were given a score of 0. One point was deducted from 139 
the total score if one or more letters were added to the target word. T-scores equal to 140 
or below 54 constitute the impaired range. 141 
Task 3: The CAT semantic associations (Sem-A) task visually presents five pictures 142 
of objects simultaneously. The instructions were to match the picture at the centre 143 
(e.g., mitten) with one of four possible alternatives according to the strongest 144 
semantic association (e.g., hand, sock, jersey, and lighthouse). The inclusion of a 145 
semantically related distractor (e.g., sock) encouraged deeper levels of semantic 146 
processing/control. There are a total of ten test trials plus a practice one at the 147 
beginning. Correct responses were given a score of 1; incorrect responses were 148 
given a score of 0. T-scores equal to or below 47 constitute the impaired range. 149 
Task 4: The CAT recognition memory (Recog-M) task visually presents each of the 150 
ten central items from the CAT semantic associations task (one at a time) along with 151 
three unrelated distractors. The instructions were to indicate which of the four 152 
pictures on display had been seen before. There are a total of ten test trials plus a 153 
practice one at the beginning. The scoring system for this task was identical to that 154 
used in the semantic associations task. T-scores equal to or below 43 constitute the 155 
impaired range. 156 
Task 5: The CAT auditory word-to-picture matching (AW-P) task involves hearing a 157 
word produced by the examiner and selecting the picture among four possible 158 
alternatives that best matches the meaning of the heard word. There are a total of 159 
8 
 
fifteen test trials plus a practice one at the beginning. Immediate correct responses 160 
were given a score of 2; incorrect responses were given a score of 0; correct 161 
responses after a self-correction or a delay (> 5 seconds) were given a score of 1. T-162 
scores equal to or below 51 constitute the impaired range. 163 
2.3. MRI data acquisition, pre-processing and lesion identification 164 
T1-weighted high resolution anatomical whole-brain volumes were available 165 
for all patients (n = 360). Four different MRI scanners (Siemens Healthcare, 166 
Erlangen, Germany) were used to acquire the structural images: 167 patients were 167 
imaged on a 3T Trio scanner, 131 on a 1.5T Sonata scanner, 57 on a 1.5T Avanto 168 
scanner, and five on a 3T Allegra scanner. For anatomical images acquired on the 169 
1.5T Avanto scanner, a 3D magnetization-prepared rapid acquisition gradient-echo 170 
(MPRAGE) sequence was used to acquire 176 sagittal slices with a matrix size of 171 
256 × 224, yielding a final spatial resolution of 1 mm isotropic voxels (repetition 172 
time/echo time/inversion time = 2730/3.57/1000 ms). For anatomical images 173 
acquired on the other three scanners, an optimised 3D modified driven equilibrium 174 
Fourier transform (MDEFT) sequence was used to acquire 176 sagittal slices with a 175 
matrix size of 256 × 224, yielding a final spatial resolution of 1 mm isotropic voxels: 176 
repetition time/echo time/inversion time = 12.24/3.56/530 ms and 7.92/2.48/910 ms 177 
at 1.5T and 3T, respectively (Deichmann et al., 2004). 178 
The T1-weighted anatomical whole-brain volume of each patient was 179 
subsequently analysed with our automated lesion identification toolbox using default 180 
parameters (for more details, see Seghier et al., 2008). This converts a scanner-181 
sensitive raw image into a quantitative assessment of structural abnormality that 182 
should be independent of the scanner used. The procedure combines a modified 183 
segmentation-normalisation routine with an outlier detection algorithm according to 184 
the fuzzy logic clustering principle (for more details, see Seghier et al., 2007). The 185 
outlier detection algorithm assumes that a lesioned brain is an outlier in relation to 186 
normal (control) brains. The output includes two 3D lesion images in standard MNI 187 
space, generated at a spatial resolution of 2 x 2 x 2 mm3. The first is a fuzzy lesion 188 
image that encodes the degree of structural abnormality on a continuous scale from 189 
0 (completely normal) to 1 (completely abnormal) at each given voxel relative to 190 
normative data drawn from a sample of 64 neurologically-normal controls. A voxel 191 
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with a high degree of abnormality (i.e. a value near to 1 in the fuzzy lesion image) 192 
therefore means that its intensity in the segmented grey and white matter deviated 193 
markedly from the normal range. The second is a binary lesion image, which is 194 
simply a thresholded (i.e. lesion/no lesion) version of the fuzzy lesion image. All our 195 
statistical analyses were based on the fuzzy images. The binary images were used 196 
to delineate the lesions, to estimate lesion size and to create lesion overlap maps.  197 
2.4. Lesion-deficit analyses 198 
We used voxel-based morphometry (Ashburner and Friston, 2000; Mechelli et 199 
al., 2005) to assess lesion-deficit relationships (Mummery et al., 2000; Tyler et al., 200 
2005), performed in SPM12 using the general linear model. The imaging data 201 
entered into the voxel-based analysis were the fuzzy (continuous) lesion images that 202 
are produced by our automated lesion identification toolbox.  203 
The most important advantage of utilising the fuzzy lesion images (as in Price 204 
et al., 2010) over alternative methods is that they provide a quantitative measure of 205 
the degree of structural abnormality, at each and every voxel of the brain, relative to 206 
neurologically-normal controls. In contrast to fuzzy lesion images, (i) binary lesion 207 
images do not provide a continuous measure of structural abnormality and will be 208 
less sensitive to subtle changes that are below an arbitrary threshold for damage 209 
(e.g., Fridriksson et al., 2013; Gajardo-Vidal et al., 2018); (ii) normalised T1 images 210 
do not distinguish between typical and atypical (abnormal) variability in brain 211 
structure (e.g., Stamatakis and Tyler, 2005); and (iii) segmented grey or white matter 212 
probability images when used in isolation (as in standard VBM routines) do not 213 
provide a complete account of the whole of the lesion (e.g., Mehta et al. 2003). 214 
In Analysis 1, the fuzzy lesion images were entered into a voxel-based 215 
multiple regression model with 6 different regressors (5 behavioural scores and 216 
lesion size); see Fig. 1. The regressor of interest was nonword repetition scores that 217 
are sensitive to difficulties articulating speech. In addition, the following regressors 218 
were included to factor out other sources of variance: written picture naming scores 219 
(which are sensitive to name retrieval abilities), semantic associations scores (which 220 
are sensitive to visual recognition and semantic processing), auditory word-to-picture 221 
matching scores (which are sensitive to auditory recognition and lexical-semantic 222 
processing), recognition memory scores (which are sensitive to picture recognition 223 
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and memory) and lesion size (to partial out linear effects of lesion size). For the 224 
voxel-based lesion-deficit analysis (with 360 patients), the search volume was 225 
restricted to voxels that were damaged in at least five patients (as in Fridriksson et 226 
al., 2016; for rationale, see Sperber and Karnath, 2017). For this purpose, a lesion 227 
overlap map based on the binary lesion images from all 360 patients was created, 228 
thresholded at five, and used as an inclusive mask before estimating the model (see 229 
Fig. 2A). Our statistical voxel-level threshold was set at p < 0.05 after family-wise 230 
error (FWE) correction for multiple comparisons (using random field theory as 231 
implemented in SPM; Flandin and Friston, 2015) across the whole search volume 232 
(for alternative approaches, see Mirman et al., 2018).  233 
Having identified a significant lesion-deficit mapping, we quantified the 234 
strength of the association between lesion and deficit by: (i) extracting the raw signal 235 
(which indexes the degree of structural abnormality) from each statistically significant 236 
voxel; (ii) averaging the signal across voxels (i.e. a single value per patient); and, 237 
finally, (iii) computing the partial correlation between lesion load in the region of 238 
interest and nonword repetition scores, after adjusting for the effect of the covariates 239 
of no interest (i.e. 4 behavioural scores and lesion size). Our measure of effect size 240 
was the proportion of variance (= R2) in nonword repetition scores explained 241 
uniquely by lesion load in the region of interest (i.e. the best estimate of the true 242 
population effect that we have). 243 
In Analysis 2, we investigated how sample size affected the reproducibility of 244 
the lesion-deficit mapping within the region of interest identified in Analysis 1. 245 
Specifically, we generated 6000 bootstrap samples of the following sizes: 360, 180, 246 
120, 90, 60 and 30 (i.e. 36000 resamples in total). These sample sizes were 247 
selected to follow as closely as possible those observed in the vast majority of 248 
published voxel-based lesion-deficit mapping studies (e.g., Dressing et al., 2018; 249 
Fridriksson et al., 2013, 2016; Halai at el., 2017; Schwartz et al., 2011, 2012). For 250 
each iteration of the resampling procedure, individuals were drawn randomly from 251 
the full set of 360 patients with replacement, meaning that the probability of being 252 
chosen remained constant throughout the selection process (i.e. the procedure 253 
satisfied the Markovian, memory-less, property). For each bootstrap sample, the 254 
partial correlation between nonword repetition scores and lesion load (averaged 255 
across voxels in the region of interest from Analysis 1) was computed. The resulting 256 
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R2 and p values were recorded, after regressing out the variance accounted for by 257 
the covariates of no interest. Of note, when we re-ran the resampling procedure 258 
outlined above with the replacement feature disabled (i.e. sampling without 259 
replacement), virtually the same results were obtained (for more details, see 260 
Supplementary Material). 261 
In addition, to rule out the possibility that variability in the results could simply 262 
be explained by differences in the distribution of damage across the brain, we 263 
quantified statistical power in the region of interest from Analysis 1 for a 264 
representative subset of bootstrap samples. Specifically, only those resamples that 265 
produced an R2 value which fell exactly at a particular decile (i.e. 0th, 10th, 266 
20th…100th) of the distribution of effect sizes were considered. This resulted in the 267 
selection of a total of 66 bootstrap samples (i.e. 11 for each sample size); see Table 268 
2. Critically, our power calculations show where in the brain there was sufficient 269 
statistical power to detect a significant lesion-deficit association at a threshold of p < 270 
0.05 after correction for multiple comparisons. The statistical power maps were 271 
generated using the “nii_powermap” function of NiiStat 272 
(https://www.nitrc.org/projects/niistat/), which is a set of Matlab scripts for analysing 273 
neuroimaging data from clinical populations. 274 
Importantly, we have chosen to assess in-sample effect sizes, i.e. without 275 
validating in a separate data set (Friston, 2012). In this context, the effect size is 276 
providing an estimate of the strength of the particular effect identified by our analysis 277 
in our data. It may be that an out-of-sample prediction - on new data - would indicate 278 
a smaller effect size. However, this would not invalidate the logic of our reasoning, 279 
particularly since the essential point we are making here is that our effect size 280 
estimate (i.e. approximately 11% in R2 terms) is very small. If there is inflation in this 281 
estimate, it could only mean that the out-of-sample effect size would be even less. 282 
Therefore, we have been able to show that even for an over-estimated effect size (if 283 
it would turn out to be), there are serious problems that arise from small sample 284 
sizes, the fallacy of classical inference, and publication bias. The impact of these 285 
issues on the reliability of the findings would only be worse if the effect size were to 286 
come down. 287 
Furthermore, we have first statistically selected an ROI in a large sample of 288 
patients, with a “left-hemisphere” analysis, and then used smaller and smaller 289 
bootstrap samples that focused on the identified ROI. In this sense, we are 290 
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performing (non-orthogonal) statistical tests in a previously selected ROI, which 291 
could potentially inflate false positive rates (Brooks et al., 2017). Consequently, the 292 
results derived from the analysis of smaller samples should not be taken as robust 293 
findings: they are being presented to make important methodological points. Our 294 
best statistical estimates of the effect considered are those obtained from the full 295 
data set. 296 
3. Results 297 
3.1. Analysis 1: identifying a region of interest 298 
Poorer speech articulation was significantly associated with greater lesion 299 
load (after controlling for written picture naming, recognition memory, semantic 300 
associations and auditory word-to-picture matching scores in addition to lesion size) 301 
in 549 voxels (= 4.4 cm3 in size; see Table 3). These voxels became our region of 302 
interest (ROI) for all subsequent analyses. They were located in parts of the left 303 
ventral primary motor and somatosensory cortices (i.e. tongue, larynx, head and face 304 
regions), anterior supramarginal gyrus, posterior insula and surrounding white matter 305 
(see Fig. 2B). 306 
This highly significant lesion-deficit relationship accounted for 11% of the 307 
variance (95% credible interval calculated using a flat prior: 0.06-0.18; Morey et al., 308 
2016); see Fig. 3. In the following analyses, we ask how sample size affects the 309 
reproducibility of the identified effect. 310 
3.2. Analysis 2: effect size variability and replicability  311 
Although the mean/median effect sizes were similar across sample sizes, the 312 
mean/median p values changed considerably with sample size (see Fig. 4), because 313 
there was wide sample-to-sample variability in the extent to which the original effect 314 
was replicated. For instance, less than 40% of the random resamples where N = 30 315 
generated significant p values, while this raised to virtually 100% for the resampled 316 
data sets where N ≥ 180. Overall, R2 values ranged between 0.00 and 0.79, whereas 317 
p values ranged between 6*10-27 and 1 (see Fig. 5A and B). Additionally, our 318 
analyses showed that, as sample size increased, R2 values tended to fall closer to 319 
the mean of the effect size distribution, although a not inconsiderable degree of 320 
uncertainty regarding R2 estimation remained (even for N = 180 and 360). In other 321 
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words, the dispersion of the R2 values tended to be larger with smaller sample sizes 322 
(see Fig. 5A), resulting in less precision in the estimation of the magnitude of the true 323 
population effect.  324 
3.2.1. Low-powered resamples can inflate effect sizes 325 
Since studies that obtain statistically non-significant results (i.e. typically p ≥ 326 
0.05) are hardly ever published (also known as the file drawer problem or study 327 
publication bias), we focused directly upon the resampled data sets that produced 328 
significant p values. For N = 30, the mean and median effect sizes of these 329 
significant resamples (i.e. roughly 37%) were 0.26 and 0.24 (range = 0.16-0.79). 330 
Conversely, the mean and median effect sizes for the N = 30 resamples where the 331 
lesion-deficit mapping did not reach statistical significance (roughly 63%) were 0.07 332 
and 0.06 (range = 0.00-0.16); see Table 4 for similar findings when N = 60. Critically, 333 
using a more stringent statistical threshold would only aggravate the problem (for 334 
more details, see Table 4). With larger sample sizes (N ≥ 90), however, effect size 335 
inflation is counteracted since both over- and under-estimations of the true effect 336 
size surpassed the threshold for statistical significance, resulting in relatively 337 
accurate mean estimates (0.13, 0.12, 0.12, and 0.11 respectively). 338 
3.2.2. High-powered resamples are sensitive to trivial/small effects 339 
The frequency with which a significant association was observed between 340 
lesion load in the ROI and nonword repetition scores increased dramatically with 341 
sample size. For example, whereas roughly 37% of the effects for N = 30 would be 342 
typically regarded as statistically significant (i.e. p < 0.05), more than 85% of the 343 
lesion-deficit mappings for N ≥ 90 generated equally low or even lower p values (see 344 
Table 4). More importantly, effects as small as 0.05 in R2 terms (i.e. that only 345 
accounted for 5% of the variance) reached statistical significance for N = 90; and this 346 
phenomenon was even more pronounced in the presence of larger sample sizes: 347 
0.02 for N = 180 (see Table 4 and Fig. 5A). Reporting point and interval estimates of 348 
effect sizes is therefore essential for assessing the importance or triviality of the 349 
identified lesion-deficit mapping, which is particularly relevant when the study uses 350 
large sample sizes.  351 
4. Discussion 352 
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The goal of this study was to examine how sample size influences the 353 
reproducibility of voxel-based lesion-deficit mappings. First, we identified a significant 354 
lesion-deficit association and estimated its magnitude using data from a very large 355 
sample of 360 patients who were all right-handed, English speaking stroke survivors 356 
with unilateral left hemisphere damage. By repeating the same analysis on 357 
thousands of bootstrap samples of different sizes we illustrate how the estimated 358 
effect size, and its statistical significance, varied across replications. This allowed us 359 
to index the degree of uncertainty in the estimation of the true population effect as a 360 
function of sample size. As expected, effect sizes were more likely to be over-361 
estimated or under-estimated with small sample sizes (i.e. variability in the results 362 
increased as sample size decreased). Conversely, we demonstrate how highly 363 
significant lesion-deficit mappings can be driven by a negligible proportion of the 364 
variance when the sample size is very large. 365 
4.1. Estimating the true effect size 366 
The first part of our investigation identified a region of interest (ROI) where 367 
damage was reliably associated with impairments in speech articulation. We then 368 
calculated what proportion of the variance in nonword repetition scores could be 369 
accounted for by the degree of damage to the identified region after factoring out 370 
confounds from auditory and visual perception, speech recognition, lexical/semantic 371 
processing and word retrieval abilities. The ROI included anatomical brain structures 372 
that have been associated with speech production in many previous lesion studies. 373 
These include the insula (Ogar et al., 2006), the precentral gyrus, the postcentral 374 
gyrus, the supramarginal gyrus and surrounding white matter (Baldo et al., 2011; 375 
Basilakos et al., 2015). It did not involve the inferior frontal gyrus/frontal operculum 376 
as reported in Hillis et al. (2004) and Baldo et al. (2011), even though our full sample 377 
incorporated plenty of patients with damage to these regions (see Fig. 2A). We do 378 
not attempt here to adjudicate whether this discrepancy was a consequence of a 379 
false negative in our study or a false positive in prior studies. Our focus was on how 380 
well the identified lesion-deficit mapping could be replicated across thousands of 381 
bootstrap samples drawn randomly from the original data set of 360 patients. For 382 
each resample, we estimated how much of the variance in nonword repetition scores 383 
could be accounted for by lesion load in the ROI (after adjusting for the effect of the 384 
covariates of no interest). These effect sizes and their statistical significance were 385 
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then compared to our best estimate of the “true” population effect size, which was 386 
found (from our full sample of 360 patients) to be 11%.  387 
4.2. Variability in the estimated effect size and its statistical significance 388 
The second part of our investigation showed that the probability of finding a 389 
significant lesion-deficit association in the ROI from the first analysis (with 360 390 
participants), depended on the size of the sample. For larger samples (N ≥ 180), the 391 
effect of interest was detected in virtually 100% of resamples. Whereas for smaller 392 
samples (N = 30), it was detected in less than 40% of resamples (see Table 4). We 393 
can also show that p values decrease as N increases, even when effect sizes are 394 
equated (see Fig. 4 and 50th percentile in Table 2). This observation is in line with 395 
prior reports that p values exhibit wide sample-to-sample variability (Cumming, 2008; 396 
Halsey et al., 2015; Vsevolozhskaya et al., 2017), particularly in the presence of 397 
small sample sizes (Hentschke and Stüttgen, 2011).  398 
When considering the central tendency of effect size estimates, the difference 399 
between larger and smaller resamples is dramatically reduced compared to that 400 
seen for p values (see mean/median effect sizes in Fig. 4). Nevertheless, even if p 401 
values were completely abandoned (e.g., Trafimow and Marks, 2015), there is still a 402 
great deal of uncertainty in the accuracy with which effect sizes can be estimated 403 
when small samples are used. This highlights the importance of reaching a better 404 
balance between null-hypothesis significance testing and effect size estimation 405 
(Chen et al., 2017; Cumming, 2014; Morey et al., 2014). Indeed, p values only 406 
indicate the likelihood of observing an effect of a given magnitude (when the null 407 
hypothesis is true). As such, they cannot convey the same information provided by 408 
point and interval estimates of effect sizes (Steward, 2016; Wasserstein and Lazar, 409 
2016), particularly since the relationship between p values and effect sizes is non-410 
linear (Hentschke and Stüttgen, 2011; Simonsohn et al., 2014a, 2014b). 411 
There are several potential reasons why the magnitude and statistical 412 
significance of the same effect varies so markedly across resamples. For example, 413 
high sample-to-sample variability could reflect (i) sampling error due to heterogeneity 414 
in the lesion-deficit association across participants (Button, 2016; Stanley and 415 
Spence, 2014), (ii) outliers that are confounding the effects (Rousselet and Pernet, 416 
2012) or (iii) measurement error (Button, 2016; Loken and Gelman, 2017; Stanley 417 
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and Spence, 2014). In this context, the field needs to adopt informed sampling 418 
strategies that ensure representative samples and maximise the probability of 419 
identifying generalizable lesion-deficit mappings (Falk et al., 2013; LeWinn et al., 420 
2017; Paus, 2010).  421 
4.3. Unreliable effect sizes in smaller samples  422 
High variance in the results of our lesion-deficit mappings with smaller 423 
samples (N = 30 and 60) demonstrates how effects can be over- as well as under-424 
estimated (e.g., Cremers et al., 2017; Ioannidis, 2008). Indeed, we show that 85% of 425 
all significant random data sets for N = 30 yielded effect size estimates that were 426 
larger than the upper bound of the credible interval (see Table 5). This is consistent 427 
with prior observations that low-powered studies (with small sample sizes) can only 428 
consistently detect large deviations from the true population effect (Szucs and 429 
Ioannidis, 2017). Put another way, even when effect sizes are accurately estimated 430 
from small samples, they are unlikely to attain statistical significance; particularly 431 
when the magnitude of the effect under investigation is small or medium. In our data, 432 
for example, we found that more than half the analyses with N = 30 that did not 433 
reach statistical significance produced effect sizes that fell within the credible interval 434 
(i.e. accurate estimations of effect sizes resulted in false negatives). Even worse, 435 
analyses of small sample sizes can invert the direction of the effect (Gelman and 436 
Carlin, 2014) as seen in our data where we found that 5% of all results for N = 30 437 
were in the wrong direction. Furthermore, reporting such findings as if they were 438 
accurate representations of reality would lead to misleading conclusions (Nissen et 439 
al., 2016). 440 
Critically, the problem was not solved but became worse when we adopted a 441 
more stringent statistical threshold, which is contrary to that proposed by Johnson 442 
(2013) and Benjamin et al. (2018). For example, if we were to raise the statistical 443 
threshold from p < 0.05 to p < 0.001 for the N = 30 resamples, the statistically 444 
significant effect sizes would range from 38% to 79% of the variance (compared to 445 
11% in the full sample of 360 patients). Increasing sample size, however, does 446 
improve accuracy, with less than 10% of significant p values associated with inflated 447 
effect sizes when N ≥ 180 (see Table 5). 448 
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Given that results are more likely to be published if they reach statistical 449 
significance than if they do not (i.e. the file drawer problem or study publication bias), 450 
our findings highlight three important implications for future lesion-deficit mapping 451 
studies. First, low-powered studies (due to small sample sizes) could lead a whole 452 
research field to over-estimate the magnitude of the true population effect. Second, 453 
power calculations based on inflated effect sizes from studies with small samples will 454 
inevitably over-estimate the statistical power associated with small sample sizes 455 
(Anderson et al., 2017). Third, although the mean effect size measured over many 456 
studies with small sample sizes will eventually converge on the true effect size, in 457 
reality, the same study is seldom replicated exactly and null results are only rarely 458 
reported. It has therefore been advocated that, contrary to current practices, it is 459 
better to carry out a few well-designed high-powered studies than it is to assimilate 460 
the results from multiple low-powered studies (Bakker et al., 2012; Higginson and 461 
Munafò, 2016). In brief, large scale studies increase the probability that an identified 462 
lesion-deficit mapping is correct (Button et al., 2013a; Szucs and Ioannidis, 2017). 463 
4.4. Trivial effect sizes in larger samples 464 
Another important observation from the current study is that, when samples 465 
are sufficiently large, relatively weak lesion-deficit associations can be deemed 466 
statistically significant (i.e. p < 0.05). For instance, effects that only accounted for as 467 
little as 3% of the variance reached statistical significance when N ≥ 120 - an 468 
inferential problem known as the fallacy of classical inference (Friston, 2012; Smith 469 
and Nichols, 2018). However, our findings are consistent with the view that this issue 470 
can be addressed by reporting point and interval estimates of effect sizes (Button et 471 
al., 2013b; Lindquist et al., 2013), which allow one to assess the practical 472 
significance (as opposed to statistical significance only) of the results. In other 473 
words, it can be argued that the fallacy of classical inference is specific to statistical 474 
tests (e.g., t, F and/or p values), leaving effect sizes largely unaffected (Reddan et 475 
al., 2017). Furthermore, there are two important advantages of conducting high-476 
powered studies: (i) they greatly attenuate the impact of study publication bias as 477 
both over- and under-estimations of the true effect size will surpass the threshold for 478 
statistical significance; and (ii) the precision with which the magnitude of the true 479 
population effect can be estimated is substantially improved (Lakens and Evers, 480 
2014; see Table 5 and Figs. 4 and 5A). Our study also indicates that, even with 481 
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sample sizes as large as N = 360, a not inconsiderable degree of uncertainty in R2 482 
estimation remained, which suggests that increasing sample size beyond this N will 483 
continue to bring benefit. 484 
4.5. Study limitations 485 
The focus of the current paper has been on establishing the degree to which 486 
the replicability of lesion-deficit mappings is influenced by sample size. To illustrate 487 
our points, we have (i) searched for brain regions where damage is significantly 488 
related to impairments in articulating speech; (ii) estimated the strength of the 489 
identified lesion-deficit association; and, (iii) run the exact same analysis on 490 
thousands of samples of varying size. However, we have not attempted to account 491 
for all possible sources of inconsistencies in univariate voxel-based lesion-deficit 492 
mapping. Nor have we investigated how our results would change if we selected 493 
another function of interest (e.g., word retrieval or phonological processing). Indeed, 494 
it has already been pointed out that higher-order functions might be associated with 495 
smaller effects than lower-level ones (Poldrack et al., 2017; Yarkoni, 2009). 496 
We also acknowledge that there are many different ways of conducting voxel-497 
based lesion-deficit analyses (for more information see de Haan and Karnath, 2018; 498 
Karnath et al., 2018; Rorden et al., 2007; Sperber and Karnath, 2018). We have 499 
selected one approach, using mass-univariate multiple regression on continuous 500 
measures of structural abnormality, behaviour and lesion size. However, we could 501 
have used other types of images or other behavioural regressors. For example, 502 
several recent studies have adopted dimensionality reduction techniques, such as 503 
principal component analysis (PCA), to transform a group of correlated behavioural 504 
measures into a smaller number of orthogonal (uncorrelated) factors (e.g., Butler et 505 
al., 2014; Corbetta et al., 2015; Mirman et al., 2015a). This PCA approach has made 506 
an important contribution to finding coarse-grained explanatory variables (e.g., Halai 507 
et al., 2017; Lacey et al., 2017; Mirman et al., 2015b; Ramsey et al., 2017), but some 508 
of its limitations are that it: (i) involves an arbitrary criterion for factor extraction; (ii) 509 
ignores unexplained variance when selecting a limited number of components; and, 510 
(iii) necessitates subjective, a posteriori, interpretation as to what the components 511 
might mean based on the factor loadings, which is not typically clear cut. Instead, we 512 
propose that a better solution for tackling orthogonality issues is to adopt both a 513 
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rigorous sampling strategy as well as behavioural measures that offer an optimal 514 
sensitivity-specificity balance. 515 
Finally, we have highlighted that the reliance on small-sized samples of 516 
patients in the presence of publication bias can undermine the inferential power of 517 
univariate voxel-based lesion-deficit analyses. However, we have not attempted to 518 
provide guidance on how prospective power calculations - that correct for the various 519 
forms of bias present in scientific publications - can be conducted. Nor have we 520 
illustrated how the presence of publication and other reporting biases in the lesion-521 
deficit mapping literature, specifically, can be ascertained. The reason simply being 522 
that others have already devoted considerable effort to developing tools that identify 523 
and deal with problems such as: (i) the excess of statistically significant findings 524 
(e.g., Ioannidis and Trikalinos, 2007); (ii) the proportion of false positives (e.g., 525 
Gronau et al., 2017); (iii) the presence of publication bias and questionable research 526 
practices (e.g., Du et al., 2017; Simonsohn et al., 2014a, 2014b); (iv) errors in the 527 
estimation of the direction and/or magnitude of a given effect (e.g., Gelman and 528 
Carlin, 2014); and, (v) sample size calculations that take into account the impact of 529 
publication bias and uncertainty on the estimation of reported effect sizes (e.g., 530 
Anderson et al., 2017). With respect to statistical power, the situation is further 531 
complicated by the fact that - in the context of univariate voxel-based lesion-deficit 532 
mapping - it not only depends on the size of the sample, the magnitude of the effect 533 
under study and the statistical threshold used (Cremers et al., 2017), but also on the 534 
distribution of damage across the brain (which is non-uniform; Inoue et al., 2014; 535 
Kimberg et al., 2007; Mah et al., 2014; Sperber and Karnath, 2017). More research 536 
on the topic will be required before prospective power calculations can be fully 537 
trusted. Until that moment, the recruitment of representative patient samples in 538 
combination with high-powered designs seems to be the best available solution to 539 
the issues discussed here.      540 
4.6. Interpreting voxel-based lesion-deficit mappings 541 
 The strength of the lesion-deficit association that we identified in a large 542 
sample of 360 patients illustrates that the majority of the variability in speech 543 
articulation abilities was driven by factors other than the degree of damage to the 544 
ROI. A clear implication of this is that the field of lesion-deficit mapping still has a 545 
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long way to go before it can inform current clinical practice, which is arguably one of 546 
its most important goals. Future studies will need to control and understand other 547 
known sources of variance (apart from lesion site and size) such as time post-stroke, 548 
age and education in order to improve our ability to predict language outcome and 549 
recovery after stroke at the individual patient level (Price et al., 2017). Furthermore, 550 
to map all the possible ways in which brain damage can affect behaviour, it will in all 551 
likelihood be necessary to use increasingly larger samples of patients (e.g., Price et 552 
al., 2010; Seghier et al., 2016) and multivariate methods (e.g., Hope et al., 2015; 553 
Pustina et al., 2018; Yourganov et al., 2016; Zhang et al., 2014). 554 
5. Conclusions 555 
This study investigated the impact of sample size on the reproducibility of 556 
voxel-based lesion-deficit mappings. We showed that: (i) highly significant lesion-557 
deficit associations can be driven by a relatively small proportion of the variance; (ii) 558 
the exact same lesion-deficit mapping can vary widely from sample to sample, even 559 
when analyses and behavioural assessments are held constant; (iii) the combination 560 
of publication bias and low statistical power can severely affect the reliability of 561 
voxel-based lesion-deficit mappings; and, finally, (iv) reporting effect size estimates 562 
is essential for assessing the importance or triviality of statistically significant 563 
findings. Solutions to the issues highlighted here will, in our view, likely involve the 564 
use of: (a) improved reporting standards; (b) increasingly larger samples of patients; 565 
(c) multivariate methods; (d) informed sampling strategies; and, (e) independent 566 
replications. Careful reflection on some deeply-rooted research practices, such as 567 
biases in favour of statistically significant findings and against null results, might also 568 
be necessary.569 
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Table 1: Summary of demographic and clinical data for full sample. 
Factor   N = 360 
Age at stroke  M 54.4 
onset (years) SD 12.9 
 
Range 17.2-86.5 
Age at testing  M 59.4 
(years) SD 12.4 
 
Range 21.3-90.0 
Time post-stroke  M 4.9 
(years) SD 5.2 
 
Range 0.2-36.0 
Education  M 14.5 
(years)* SD 3.2 
 
Range 10.0-30.0 
Lesion size  M 85.7 
(cm3) SD 87.6 
 Range 1.5-386.2 
Gender Males 250 
 Females 110 
Rep-N Imp/Non 132/228 
 
M 54.4 
 
SD 9.1 
Writt-PN Imp/Non 105/255 
 
M 58.6 
 
SD 8.7 
Recog-M Imp/Non 37/323 
 
M 53.9 
 
SD 7.0 
Sem-A Imp/Non 36/324 
 
M 56.6 
 
SD 6.1 
AW-P Imp/Non 77/283 
 
M 57.0 
 
SD 6.8 
 
Imp/Non = number of patients with impaired/non-impaired performance. *Missing 
data: three patients. 
 
 
 
 
23 
 
Table 2: Statistical power in the region of interest. 
 
%tile  Sample Size 
 
 30 60 90 120 180 360 
0th Power 98% 100% 100% 100% 100% 100% 
 R
2 0.00 0.00 0.00 0.00 0.00 0.01 
 P 0.999 0.999 0.999 0.999 0.404 0.093 
10th Power 99% 100% 100% 100% 100% 100% 
 R
2 0.01 0.03 0.04 0.05 0.06 0.07 
 P 0.638 0.218 0.064 0.015 0.001 0.000 
20th Power 63% 100% 100% 100% 100% 100% 
 R
2 0.03 0.05 0.06 0.07 0.08 0.09 
 P 0.400 0.093 0.022 0.004 0.000 0.000 
30th Power 86% 100% 100% 100% 100% 100% 
 R
2 0.06 0.07 0.08 0.08 0.09 0.10 
 P 0.250 0.046 0.009 0.002 0.000 0.000 
40th Power 92% 100% 100% 100% 100% 100% 
 R
2 0.08 0.09 0.10 0.10 0.10 0.11 
 P 0.158 0.025 0.004 0.001 0.000 0.000 
50th Power 98% 100% 100% 100% 100% 100% 
 R
2 0.11 0.11 0.11 0.11 0.11 0.11 
 P 0.099 0.012 0.002 0.000 0.000 0.000 
60th Power 100% 100% 100% 100% 100% 100% 
 R
2 0.15 0.14 0.13 0.13 0.13 0.12 
 P 0.060 0.006 0.001 0.000 0.000 0.000 
70th Power 83% 100% 100% 100% 100% 100% 
 R
2 0.18 0.16 0.15 0.14 0.14 0.13 
 P 0.032 0.002 0.000 0.000 0.000 0.000 
80th Power 96% 100% 100% 100% 100% 100% 
 R
2 0.23 0.19 0.17 0.16 0.15 0.14 
 P 0.015 0.001 0.000 0.000 0.000 0.000 
90th Power 100% 100% 100% 100% 100% 100% 
 R
2 0.30 0.23 0.21 0.19 0.18 0.16 
 P 0.004 0.000 0.000 0.000 0.000 0.000 
100th Power 99% 100% 100% 100% 100% 100% 
 R
2 0.79 0.52 0.39 0.39 0.38 0.28 
 P 0.000 0.000 0.000 0.000 0.000 0.000 
 
The table shows that in all but one case, more than 80% of the voxels comprising the 
region of interest from Analysis 1 had sufficient statistical power to detect a 
significant lesion-deficit association at a threshold of p < 0.05 after correction for 
multiple comparisons. %tile = percentile of the effect size (R2) distribution; Power = 
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percentage of voxels within the region of interest from Analysis 1 that had sufficient 
statistical power to detect a significant lesion-deficit association at a statistical 
threshold of p < 0.05 after correction for multiple comparisons; R2 = R2 value (at a 
particular decile); P = p value (at a particular decile). 
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Table 3: Brain regions where lesion load is associated with speech articulation 
abilities. 
 
Brain region Peak coordinates Voxel-level Cluster-level 
 
x y z Z-score PFWE-corr Extent PFWE-corr 
Post-Central  -60 -16 12 5.8 0.000 549* < 0.001 
 -52 -14 24 4.7 0.009   
 -56 -12 18 4.6 0.012   
Posterior Insula -40 -16 8 5.3 0.001   
Anterior SMG -66 -30 20 4.7 0.008   
WM -48 -24 26 4.6 0.010 
  
 
The table shows representative (peak) voxels where a significant association 
between stroke damage and difficulties articulating speech was found. All were in the 
left hemisphere and the coordinates are reported in MNI space. SMG = 
supramarginal gyrus; WM = white matter; PFWE-corr = p value corrected (family-wise 
error correction) for multiple comparisons. *At a cluster-forming voxel-wise threshold 
of p < 0.05 FWE-corrected. 
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Table 4: Mean and median effect size of the significant and non-significant random 
data sets by sample size. 
 
R
2
 Sample Size 
 30 60 90 120 180 360 
 
s ns s ns s ns s ns s ns s ns 
Count 2214 3786 4272 1728 5289 711 5747 253 5974 26 5999 1 
 258 5742 1279 4721 2613 3387 3911 2089 5369 631 5997 3 
M 0.26 0.07 0.16 0.04 0.13 0.03 0.12 0.02 0.12 0.01 0.11 --- 
 0.45 0.12 0.24 0.09 0.18 0.07 0.15 0.06 0.12 0.05 0.11 0.02 
Mdn 0.24 0.06 0.15 0.04 0.12 0.03 0.11 0.02 0.11 0.01 0.11 --- 
 0.43 0.11 0.23 0.09 0.17 0.08 0.14 0.06 0.12 0.05 0.11 0.03 
Min 0.16 0.00 0.07 0.00 0.05 0.00 0.03 0.00 0.02 0.00 0.03 0.01 
 0.38 0.00 0.19 0.00 0.12 0.00 0.09 0.00 0.06 0.00 0.03 0.01 
Max 0.79 0.16 0.52 0.07 0.39 0.05 0.39 0.03 0.38 0.02 0.28 0.01 
 0.79 0.38 0.52 0.19 0.39 0.12 0.39 0.09 0.38 0.06 0.28 0.03 
 
For each summary statistic, the upper row indicates the corresponding value when 
the alpha threshold was set at 0.05, whereas the lower row indicates the 
corresponding value when the alpha threshold was set at 0.001. Count = the number 
of resampled data sets that generated significant or non-significant R2 values; s = 
significant (i.e. p < α); ns = not significant (i.e. p ≥ α); M = mean R2 value; Mdn = 
median R2 value; Min = minimum R2 value; Max = maximum R2 value. 
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Table 5: Frequency of accurate and inaccurate effect size estimates by sample size 
and statistical significance. 
 
N Effect Size 
 Significant Not significant 
  > 95% CI = 95% CI < 95% CI > 95% CI = 95% CI < 95% CI 
360 173 5686 140 0 0 1 
180 556 4925 493 0 0 26 
120 795 4430 522 0 0 253 
90 1081 3887 321 0 0 711 
60 1417 2855 0 0 421 1307 
30 1873 341 0 0 2007 1779 
 
The table shows, for each sample size, the frequency with which effect size 
estimates reached statistical significance (i.e. p < 0.05) and fell within (=) or outside 
the 95% credible interval (i.e. 0.06-0.18) of the best estimate of the “true” population 
effect (i.e. R2 = 0.11). 95% CI = 95% credible interval; > = larger than the upper 
bound of 95% CI; < = smaller than the lower bound of 95% CI. 
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Fig. 1. Design matrix. The design matrix for Analysis 1 is shown, where the columns 
represent the subject-specific independent variables (IVs), with one value for each 
subject, and the rows correspond to the dependent variable (DV) indexing the 
degree of structural abnormality in the fuzzy lesion images. 
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Fig. 2. Lesion overlap map and region of interest from Analysis 1. (A) Lesion overlap 
map for the full sample of 360 stroke patients, depicting voxels that were damaged in 
a minimum of 5 and a maximum of 215 patients. The colour scale indicates the 
number of patients with overlapping lesions at each given voxel. (B) In red, the 
region of interest identified in Analysis 1 (i.e. 549 voxels) where a significant 
association between lesion load and speech articulation abilities was found. 
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Fig. 3. Effect of interest. Visual illustration of the strength of the relationship between 
lesion load in the region of interest and nonword repetition scores, after factoring out 
variance explained by the covariates of no interest (i.e. a plot of the lesion load and 
nonword repetition residuals; Analysis 1). 
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Fig. 4. Differential sensitivity of effect sizes and p values to sample size. The figure 
highlights that, while the mean and median of the effect size distributions remained 
relatively constant across the different sample sizes, the mean and median of the p 
value distributions exhibited substantial and systematic variability. Box plots depict 
medians with interquartile ranges and whiskers represent the 5th and 95th 
percentiles. The crosses indicate the mean for each sample size. The horizontal 
dashed line in red signals the R2 value obtained in Analysis 1 (including data from all 
360 patients), whereas the horizontal dashed line in blue shows the standard alpha 
level (i.e. 0.05). 
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Fig. 5. Distribution of R2 and p values. (A) From left to right, the frequency (in 
intervals of 0.02) and probability distributions of effect sizes for each sample size. 
The vertical dotted lines indicate the boundary between non-significant (p ≥ 0.05; to 
the left) and significant (p < 0.05; to the right) R2 values. (B) From left to right, the 
frequency (in intervals of 0.05) and probability distributions of p values for each 
sample size. 
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 The same lesion-deficit analysis was repeated on thousands of bootstrap 
samples. 
 Replicability of the original effect was contingent upon the size of the sample. 
 With smaller samples, only inflated effect size estimates reached significance. 
 With larger samples, even trivial effect sizes yielded significant p values. 
 
